Medication info
Telmisartan Plus Tablet 80/25 mg

Telmisartan Plus Tablet 80/25 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›25mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
It is a white or almost white-yellow, egg-shaped tablet composed of two layers, and the white layer may have yellow spots.
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201004700 · Notified 2010.07.27 · Insurance code 643305770

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
Adults Take once daily with a beverage, with or without food, for patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be adjusted individually. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given together as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is needed in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Administer this medicine with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine daily. Do not administer this medicine to patients with severe hepatic impairment (see section 2 of Precautions for Use). Thiazide diuretics should be administered with caution to patients with impaired hepatic function. Elderly patients No dose change is needed.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

This medication is used to treat essential hypertension. Telmisartan 80 mg and Hydrochlorothiazide 12.5 mg are administered as a single-agent or in combination to effectively lower blood pressure in patients whose blood pressure is not adequately controlled. Therefore, this medication helps improve blood pressure control in hypertensive patients.

How to take

Adult dose

Adults Take once daily with a beverage, with or without food, for patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be adjusted individually. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given together as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is needed in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Administer this medicine with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine daily. Do not administer this medicine to patients with severe hepatic impairment (see section 2 of Precautions for Use). Thiazide diuretics should be administered with caution to patients with impaired hepatic function. Elderly patients No dose change is needed.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. If pregnancy is confirmed, treatment with this medication should be stopped immediately and replaced with another safe treatment. This medication should not be administered to individuals with hypersensitivity to its ingredients, pregnant or breastfeeding women, or patients with severe liver or kidney dysfunction. Additionally, it should not be used in patients with bile duct obstruction, acute glomerulonephritis, or anuria. Caution is advised when administering this medication to the elderly or patients with impaired liver function, elevated serum potassium levels, or heart disease. Since this medication lowers blood pressure, excessive hypotension can lead to myocardial infarction or stroke. Regular blood tests are necessary to monitor electrolyte levels, as Hydrochlorothiazide can cause fluid and electrolyte imbalance. This medication may increase serum potassium levels, so caution is needed when it is used with potassium supplements or medications high in potassium. Furthermore, this medication contains sorbitol, making it unsuitable for patients with fructose intolerance. Caution should also be taken when driving or operating machinery, as symptoms such as dizziness or drowsiness may occur. During the course of treatment, exposure to sunlight or ultraviolet light should be limited, and any skin abnormalities should be reported to a doctor immediately. There are many interactions with other medications, so inform your doctor or pharmacist of any medications you are taking. In case of overdose, symptoms such as hypotension, electrolyte abnormalities, and dehydration may occur, and immediate medical attention is necessary. Safety has not been established for individuals under 18 years old, so it is not recommended. This medication should be stored out of reach of children and transferred to a different container should be avoided.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 112 more
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver dysfunction
  • liver disease
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle spasms
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased blood creatine phosphokinase
  • increased liver enzymes
  • upper respiratory infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • eczema
  • drug rash
  • toxic skin eruption
  • bone pain
  • kidney dysfunction
  • weakness
  • influenza-like illness
  • increased blood creatine
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • jaundice
  • cholestasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • acute respiratory distress syndrome
  • pancreatitis
  • facial flushing
  • malaise
  • fatigue
  • nausea
  • headache
  • gastrointestinal bleeding
  • esophagitis
  • tremors
  • proteinuria
  • pruritus
  • myalgia
  • feeling of unreality
  • lip and hand tremors
  • sensory hyperesthesia
  • visual decline
  • hypotension
  • tachycardia
  • hypokalemia
  • hypochloremia
  • dehydration
  • nausea
  • somnolence
  • muscle cramps

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should be kept at room temperature between 1 and 30 degrees Celsius. This ensures that the effect of the medication is preserved safely for a long time.

Appearance and packaging

Appearance

It is a white or almost white-yellow, egg-shaped tablet composed of two layers, and the white layer may have yellow spots.

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.